NCT06329622

Effect of Ketosteril on Sarcopenia in Patients With Chronic Kidney Disease

Ketosteril Sarcopenia Chronic Kidney Disease

• Status: Recruiting
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 58 (estimated)
• Sponsor: Huashan Hospital · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

The investigators hypothesize that Ketosteril can improve sarcopenia in patients with renal disease without increasing the burden on the kidneys and causing deterioration of renal function. Therefore, this study intends to take patients with CKD stage 3-4 and sarcopenia as the research object, give Ketosteril intervention or not to patients on the base of low-protein diet, and clarify the clinical benefits of Ketosteril prescription for improving sarcopenia in patients with CKD.

Conditions

• Chronic Kidney Disease
• Sarcopenia

Interventions

Type	Name	Description
COMBINATION_PRODUCT	low-protein diet + Ketosteril	low-protein diet (0.6-0.8g protein/kg body weight/day) and Ketosteril 0.12 g/kg body weight/day will be prescribed with the target energy intake of 25-30kcal/kg body weight/day.
DIETARY_SUPPLEMENT	low-protein diet	low-protein diet (0.6-0.8g protein/kg body weight/day) with the target energy intake of 25-30kcal/kg body weight/day.

Timeline

• Start date: 2024-05-01
• Primary completion: 2026-06-30
• Completion: 2026-06-30
• First posted: 2024-03-26
• Last updated: 2024-10-15

Locations

1 site across 1 country: China